KEGG   DISEASE: 注意欠陥多動障害 (ADHD)
エントリ  
H01895                                                             
名称    
注意欠陥多動障害 (ADHD)
概要    
Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder first diagnosed in childhood and frequently persistent throughout adult life. The disorder is classically characterized by symptoms of inattention, impulsivity, and hyperactivity. Many children with ADHD go on to have problems related to education, social functioning, and/or other mental illness as adolescents and young adults. Although heritability estimates are consistently high, ADHD is a genetically complex disorder characterized by multifactorial inheritance involving numerous genes of moderate effect. Reports implicate variants of genes important for the synthesis, uptake, transport and receptor binding of dopamine in the etiology of ADHD. And interaction between the dopamine and serotonin systems has been implicated in both the pathophysiology of ADHD and the mechanism of action of widely used stimulant compounds.
カテゴリ  
精神及び行動の障害
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 06 精神, 行動, 神経発達の障害
  神経発達症
   6A05  注意欠如多動症
    H01895  注意欠陥多動障害 (ADHD)
パスウェイに基づく疾患分類 [BR:jp08402]
 アミノ酸代謝
  nt06028  ドパミンとセロトニンの代謝
   H01895  注意欠陥多動障害 (ADHD)
 細胞プロセス
  nt06544  神経刺激性リガンドのシグナリング
   H01895  注意欠陥多動障害 (ADHD)
パスウェイ 
hsa00380  Tryptophan metabolism
hsa04728  Dopaminergic synapse
hsa04726  Serotonergic synapse
hsa04082  Neuroactive ligand signaling
ネットワーク
nt06028 Dopamine and serotonin metabolism
nt06544 Neuroactive ligand signaling
病因遺伝子 
(ADHD) DRD5 [HSA:1816] [KO:K05840]
(ADHD) DRD4 [HSA:1815] [KO:K04147]
(ADHD7) TPH2 [HSA:121278] [KO:K00502]
(ADHD8) CDH2 [HSA:1000] [KO:K06736]
治療薬   
グアンファシン塩酸塩 [DR:D00606]
メチルフェニデート塩酸塩 [DR:D01296]
アトモキセチン塩酸塩 [DR:D02574]
リスデキサンフェタミンメシル酸塩 [DR:D04747]
リンク   
ICD-11: 6A05
MeSH: D001289
OMIM: 143465 613003 619957
文献    
  著者
Matthews M, Nigg JT, Fair DA
  タイトル
Attention deficit hyperactivity disorder.
  雑誌
Curr Top Behav Neurosci 16:235-66 (2014)
DOI:10.1007/7854_2013_249
文献    
  著者
Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P
  タイトル
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
  雑誌
Curr Med Res Opin 30:1673-85 (2014)
DOI:10.1185/03007995.2014.904772
文献    
  著者
Bello NT
  タイトル
Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents.
  雑誌
Patient Prefer Adherence 9:877-85 (2015)
DOI:10.2147/PPA.S73167
文献    
PMID:14699430 (ADHD)
  著者
Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF
  タイトル
Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
  雑誌
Mol Psychiatry 9:711-7 (2004)
DOI:10.1038/sj.mp.4001466
文献    
PMID:16116490 (ADHD7)
  著者
Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer Ch, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knolker U, Friedel S, Schafer H, Gross C, Hebebrand J, Warnke A, Lesch KP
  タイトル
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder.
  雑誌
Mol Psychiatry 10:1126-32 (2005)
DOI:10.1038/sj.mp.4001734
文献    
PMID:34702855 (ADHD8)
  著者
Halperin D, Stavsky A, Kadir R, Drabkin M, Wormser O, Yogev Y, Dolgin V, Proskorovski-Ohayon R, Perez Y, Nudelman H, Stoler O, Rotblat B, Lifschytz T, Lotan A, Meiri G, Gitler D, Birk OS
  タイトル
CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice.
  雑誌
Nat Commun 12:6187 (2021)
DOI:10.1038/s41467-021-26426-1
LinkDB    

» English version

DBGET integrated database retrieval system